L631-0675 Screening compound: 2-(4-fluorophenyl)-1-(1-methyl-3-{[4-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone

L631-0675 Screening compound: 2-(4-fluorophenyl)-1-(1-methyl-3-{[4-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone
L631-0675 Screening compound: 2-(4-fluorophenyl)-1-(1-methyl-3-{[4-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone alternative view

Chemical Structure Depiction of ChemDiv screening compound L631-0675
2-(4-fluorophenyl)-1-(1-methyl-3-{[4-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L631-0675

Molecular Formula

C26H32FN5O3 (C26 H32 FN5 O3)

Compound Name

2-(4-fluorophenyl)-1-(1-methyl-3-{[4-(1-pyrrolidinylcarbonyl)piperidino]carbonyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-1-ethanone

IUPAC name

2-(4-fluorophenyl)-1-{1-methyl-3-[4-(pyrrolidine-1-carbonyl)piperidine-1-carbonyl]-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl}ethan-1-one

SMILES

Cn1nc(C(N(CC2)CCC2C(N2CCCC2)=O)=O)c(C2)c1CCN2C(Cc(cc1)ccc1F)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.463

Distribution Coefficient, logD

1.463

Water Solubility, LogSw

-1.92

Polar Surface Area

64.702

Acid Dissociation Constant (pKa)

16.90

Base Dissociation Constant (pKb)

3.51

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

53.85

L631-0675 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L631-0675 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L631-0675?
Check Price and Availability of L631-0675, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L631-0675 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L631-0675
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L631-0675
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L631-0675 available by request